COMPASS Pathways Plc (CMPS)

COMPASS Pathways Plc (CMPS $4.39)
- $4.39 Cap: $421M
- View CMPS Profile
- View Questions on CMPS

{tplLang.businessdescription | toLang tLang}

{ profileData.description }

{tplLang.details | toLang tLang}

{tplLang.ceo | toLang tLang}

{profileData.profile.details.ceo}

{tplLang.employees | toLang tLang}

{profileData.profile.details.employees | numeraljs '0,0'}

{tplLang.issuetype | toLang tLang}

{profileData.profile.details.issuetype | asIssueType}

{tplLang.industryclassifications | toLang tLang}

{tplLang.sector | toLang tLang}

{profileData.profile.classification.sector}

{tplLang.industry | toLang tLang}

{profileData.profile.classification.industry}

{tplLang.toolname| toLang tLang}

There is no {tplLang.toolname| toLang tLang} currently available for {data.symbolstring}.

COMPASS Pathways Plc (CMPS $4.39)
- $4.39 Cap: $421M
- View CMPS Profile
- View Questions on CMPS
Delic Holdings Corp Com Sub Vtg (DELC $0.01)
- View DELC Profile
- View Questions on DELC

Q: Peter

This company, no doubt, is beyond speculative, but would you be able to provide some background/insight. If one were interested in getting into the "psychedelic wellness" trend, would you also suggest any other companies. This is a long term/far-reaching investment, whose concepts are very intriguing to me.

Read Answer Asked by Sylvia on April 03, 2023

COMPASS Pathways Plc (CMPS $4.39)
- $4.39 Cap: $421M
- View CMPS Profile
- View Questions on CMPS

Q: Hello, what are your thoughts of the psilocybin therapeutics sector? Personally, I believe there should be a much better alternative available today to treating mental health issues than our current options. I've read the FDA gave 'Breakthrough Therapy Designation' to COMP360 (by Compass Pathways), and I find this very hopeful. However, as an investment for the next 1-2 years what are you thoughts of this industry and this company (or any company)? Do you see this as just another boom and bust as did the cannabis sector?

Much thx.

Read Answer Asked by Henry on January 11, 2021